Suzuken Co., Ltd. (TYO:9987)

Market Cap	431.92B +21.2%
Revenue (ttm)	2.45T +1.5%
Net Income	34.84B +1.9%
EPS	490.34 +10.7%
Shares Out	67.74M
PE Ratio	13.00
Forward PE	14.28
Dividend	100.00 (1.55%)
Ex-Dividend Date	Mar 30, 2026

Volume	236,800
Average Volume	197,085
Open	6,472.00
Previous Close	6,376.00
Day's Range	6,414.00 - 6,524.00
52-Week Range	4,406.00 - 6,668.00
Beta	0.14
RSI	49.40
Earnings Date	Feb 12, 2026

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplie...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1932
• Employees: 12,923
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9987

Financial Performance

In fiscal year 2025, Suzuken's revenue was 2.40 trillion, an increase of 0.56% compared to the previous year's 2.39 trillion. Earnings were 34.50 billion, an increase of 18.89%.